TROV - .3621 Pre-market now at .3803/.385 Trovagene Presents Data at AACR Meeting 2018 Showing Synergy of PCM-075 in Combination with FLT3 Inhibitors in Acute Myeloid Leukemia (AML) http://stockcharts.com/c-sc/sc?s=TROV&p=D&b=5&g=0&i=t40484626105&r=1523885167325 http://stockcharts.com/c-sc/sc?s=TROV&p=W&b=5&g=0&i=t28630628001&r=1523885187407